Pharmaceutical giant Pfizer made the list with a dividend yield of 7.65%, a payout ratio over the past 12 months of 118.4%, and a debt-to-equity ratio of 76.2%. Pfizer has taken a hit over the past week, seeing a decline of more than 6%, lagging the broader market. Shares of Pfizer, along with those of other industry giants like AbbVie, Merck, and Eli Lilly, came under pressure earlier this week when Trump said the U.S. would announce “very shortly a major tariff on pharmaceuticals.” The stock underperformed the broader market in recent months, falling about 26% over the past six months and more than 19% over the past three.
In comparison, the S&P 500 lost more than 9% during both time frames. On Thursday, Chevron was on pace for a negative week, having experienced a week-to-date tumble of nearly 6%. The energy company has a dividend yield of 4.68%, a payout ratio of 66.8%, and a total debt-to-equity ratio of 19.3%.
Pfizer faces tariff-induced pressure
This week, Scotiabank downgraded Chevron to sector perform from sector outperform and cut its price target to $143 from $160, implying limited upside potential of about 6% from Thursday’s close. “We think CVX has a higher likelihood of reducing their current buyback run rate from the recent annual pace of ~$17.5B to $10.0B in the coming quarters,” analyst Paul Cheng wrote in a note to clients dated Thursday.
In comparison, they believe ExxonMobil (XOM) has a higher probability of maintaining its current payout pace. Most analysts on Wall Street maintain a bullish stance on Chevron. Of the 25 total analysts covering the company, 17 have a strong buy or buy rating, according to data from LSEG.
Meanwhile, food stock Kraft Heinz has a 5.5% dividend yield, a 70.4% payout ratio, and a 41.5% debt-to-equity ratio. Shares were also on pace for a weekly loss, shedding more than 2%.
Photo by; Mufid Majnun on Unsplash